EBR vs NAN

ASX Healthcare sector comparison — updated 14 Jul 2026 — Healthcare sector

EBR

EBR SYSTEM CDI FORUS [EBR]

45LOW

NAN

NANOSONICS FPO [NAN]

52MEDIUM

Score Breakdown

EBR NAN
Technical
47
49
Catalyst
55
53
Sentiment
50
50
Fundamental
42
94
Momentum
23
41
Risk Gate
42
40

Key Metrics

EBR Metric NAN
$175.7MMarket Cap$965.5M
2.8MAvg Volume (20d)440K
+0.1%Short Interest+6.9%
$1.47552-Week High$4.770
$0.36552-Week Low$2.960
-2.6%Daily Change-0.3%
$0.380Reference Price$3.220
-458.8%ROE+10.1%
N/AProfit Margin+9.9%

Active Signals

EBR Signals

●RSI drifting toward oversold territory — worth watching
●Trading below both moving averages — the trend is working against this one
●Drifting lower — down 3.8% over the last 5 days
●Volume-price trend says buyers are quietly accumulating — price hasn't caught up yet
●Below the 200-day average — the long-term trend is still working against it
●Critical cash runway (2.0 quarters)
●EPS estimates revised downward (-10pts)
●Near 52-week low (2% of range)

NAN Signals

●MACD momentum is losing steam
●Stochastic is deep in oversold territory — bounce conditions forming
●Below the 200-day average — the long-term trend is still working against it
●Cash positive / operating cashflow positive
●Low P/S ratio (4.7x)
●Moderate revenue growth (+9%)
●Piotroski F-Score strong (8/9, low-confidence approx)
●EPS estimates revised upward (+3pts)

Ask Scout AI to compare EBR and NAN in depth.

Open Scout AI →

Track both stocks and 2,200+ more — Free

Daily AI-powered screening across every ASX small cap.

Open Screener

Related Comparisons

EBR vs NOX →EBR vs NSB →EBR vs NTI →EBR vs NUZ →EBR vs NXN →
EBR Full Analysis → NAN Full Analysis → Healthcare Sector → All Comparisons →
GENERAL INFORMATION ONLY. SmallCapData provides algorithmic screening data and does not constitute personal financial advice, a recommendation, or an offer to buy or sell any security. This content is produced by an algorithm, not a licensed financial adviser. You should consider seeking independent financial advice before making any investment decision. Past performance is not indicative of future results. Trading in small-cap securities carries a high degree of risk, including the risk of total loss of capital. The author may hold positions in mentioned securities. SmallCapData does not hold an Australian Financial Services Licence (AFSL).